Literature DB >> 20607535

FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion.

Masatoyo Nakajo1, Yoriko Kajiya, Tomoyo Kaneko, Youichi Kaneko, Takashi Takasaki, Atsushi Tani, Masako Ueno, Chihaya Koriyama, Masayuki Nakajo.   

Abstract

PURPOSE: To correlate both primary lesion (18)F-fluorodeoxyglucose (FDG) maximum standardized uptake value (SUVmax) and diffusion-weighted imaging (DWI) apparent diffusion coefficient (ADC) with clinicopathological prognostic factors and compare the prognostic value of these indexes in breast cancer.
METHODS: The study population consisted of 44 patients with 44 breast cancers visible on both preoperative FDG PET/CT and DWI images. The breast cancers included 9 ductal carcinoma in situ (DCIS) and 35 invasive ductal carcinomas (IDC). The relationships between both SUVmax and ADC and clinicopathological prognostic factors were evaluated by univariate and multivariate regression analysis and the degree of correlation was determined by Spearman's rank test. The patients were divided into a better prognosis group (n = 24) and a worse prognosis group (n = 20) based upon invasiveness (DCIS or IDC) and upon their prognostic group (good, moderate or poor) determined from the modified Nottingham prognostic index. Their prognostic values were examined by receiver operating characteristic analysis.
RESULTS: Both SUVmax and ADC were significantly associated (p<0.05) with histological grade (independently), nodal status and vascular invasion. Significant associations were also noted between SUVmax and tumour size (independently), oestrogen receptor status and human epidermal growth factor receptor-2 status, and between ADC and invasiveness. SUVmax and ADC were negatively correlated (ρ=-0.486, p = 0.001) and positively and negatively associated with increasing of histological grade, respectively. The threshold values for predicting a worse prognosis were ≥4.2 for SUVmax (with a sensitivity, specificity and accuracy of 80%, 75% and 77%, respectively) and ≤0.98 for ADC (with a sensitivity, specificity and accuracy of 90%, 67% and 77%, respectively).
CONCLUSION: SUVmax and ADC correlated with several of pathological prognostic factors and both indexes may have the same potential for predicting the prognosis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607535     DOI: 10.1007/s00259-010-1529-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  39 in total

Review 1.  Pathological prognostic factors in breast cancer.

Authors:  C W Elston; I O Ellis; S E Pinder
Journal:  Crit Rev Oncol Hematol       Date:  1999-08       Impact factor: 6.312

2.  In vivo diffusion-weighted MRI of the breast: potential for lesion characterization.

Authors:  Shantanu Sinha; Flora Anne Lucas-Quesada; Usha Sinha; Nanette DeBruhl; Lawrence W Bassett
Journal:  J Magn Reson Imaging       Date:  2002-06       Impact factor: 4.813

Review 3.  Evolving role of positron emission tomography in breast cancer imaging.

Authors:  William B Eubank; David A Mankoff
Journal:  Semin Nucl Med       Date:  2005-04       Impact factor: 4.446

4.  Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Authors:  N Avril; M Menzel; J Dose; M Schelling; W Weber; F Jänicke; W Nathrath; M Schwaiger
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

5.  Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging.

Authors:  Yong Guo; You-Quan Cai; Zu-Long Cai; Yuan-Gui Gao; Ning-Yu An; Lin Ma; Srikanth Mahankali; Jia-Hong Gao
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

6.  Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.

Authors:  Sung Hun Kim; Eun Suk Cha; Hyeon Sook Kim; Bong Joo Kang; Jae Jeong Choi; Ji Han Jung; Yong Gyu Park; Young Jin Suh
Journal:  J Magn Reson Imaging       Date:  2009-09       Impact factor: 4.813

Review 7.  Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.

Authors:  Nicoletta Biglia; Luca Mariani; Luca Sgro; Paola Mininanni; Giulia Moggio; Piero Sismondi
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

Review 8.  Optimal management of ductal carcinoma in situ of the breast.

Authors:  George H Sakorafas; David R Farley
Journal:  Surg Oncol       Date:  2003-12       Impact factor: 3.279

9.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up.

Authors:  S E Pinder; I O Ellis; M Galea; S O'Rouke; R W Blamey; C W Elston
Journal:  Histopathology       Date:  1994-01       Impact factor: 5.087

10.  Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.

Authors:  Tomoo Inoue; Kenji Yutani; Tetsuya Taguchi; Yasuhiro Tamaki; Eiichi Shiba; Shinzaburo Noguchi
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-24       Impact factor: 4.553

View more
  35 in total

1.  Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.

Authors:  Vincent Vinh-Hung; Hendrik Everaert; Jan Lamote; Mia Voordeckers; Hilde van Parijs; Marian Vanhoeij; Guy Verfaillie; Christel Fontaine; Hansjoerg Vees; Osman Ratib; Georges Vlastos; Mark De Ridder
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-10       Impact factor: 9.236

Review 2.  Imaging and evaluation of patients with high-risk prostate cancer.

Authors:  Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

3.  18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.

Authors:  Yoshifumi Noda; Masayuki Kanematsu; Satoshi Goshima; Natsuko Suzui; Yoshinobu Hirose; Kengo Matsunaga; Hironori Nishibori; Hiroshi Kondo; Haruo Watanabe; Hiroshi Kawada; Nobuyuki Kawai; Yukichi Tanahashi; Kyongtae T Bae
Journal:  Eur Radiol       Date:  2015-04-09       Impact factor: 5.315

4.  Quantitative parameters of MRI and 18F-FDG PET/CT in the prediction of breast cancer prognosis and molecular type: an original study.

Authors:  Pavel Borisovich Gelezhe; Ivan Andreevich Blokhin; Damir Ildarovich Marapov; Sergey Pavlovich Morozov
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

5.  The Prognostic Value of (18)F-FDG PET/CT for Early Recurrence in Operable Breast Cancer: Comparison with TNM Stage.

Authors:  Joo Hyun O; Woo Hee Choi; Eun Ji Han; Eun-Kyoung Choi; Byung Joo Chae; Yong-Gyu Park; Sung Hoon Kim
Journal:  Nucl Med Mol Imaging       Date:  2013-09-13

6.  Voxelwise analysis of simultaneously acquired and spatially correlated 18 F-fluorodeoxyglucose (FDG)-PET and intravoxel incoherent motion metrics in breast cancer.

Authors:  Jason Ostenson; Akshat C Pujara; Artem Mikheev; Linda Moy; Sungheon G Kim; Amy N Melsaether; Komal Jhaveri; Sylvia Adams; David Faul; Christopher Glielmi; Christian Geppert; Thorsten Feiweier; Kimberly Jackson; Gene Y Cho; Fernando E Boada; Eric E Sigmund
Journal:  Magn Reson Med       Date:  2016-10-25       Impact factor: 4.668

7.  Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.

Authors:  B B Koolen; M J T F D Vrancken Peeters; J Wesseling; E H Lips; W V Vogel; T S Aukema; E van Werkhoven; K G A Gilhuijs; S Rodenhuis; E J Th Rutgers; R A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-16       Impact factor: 9.236

8.  Dual-Time 18F-FDG PET/CT Imaging in Initial Locoregional Staging of Breast Carcinoma: Comparison with Conventional Imaging and Pathological Prognostic Factors.

Authors:  Aynur Ozen; Serdar Altinay; Ozgul Ekmekcioglu; Ramazan Albayrak; Ali Muhammedoglu; Hakan Yigitbas; Eylem Bastug; Atilla Celik
Journal:  Indian J Surg       Date:  2016-04-23       Impact factor: 0.656

9.  Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors.

Authors:  Paolo Belli; Melania Costantini; Enida Bufi; Giuseppe Giovanni Giardina; Pierluigi Rinaldi; Gianluca Franceschini; Lorenzo Bonomo
Journal:  Radiol Med       Date:  2014-08-06       Impact factor: 3.469

10.  Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.

Authors:  Michiro Sasaki; Mitsuhiro Tozaki; Kazunori Kubota; Wakana Murakami; Daisuke Yotsumoto; Yasuaki Sagara; Yasuyo Ohi; Shunichi Oosako; Yoshiaki Sagara
Journal:  Jpn J Radiol       Date:  2017-11-20       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.